Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 33% ± 15% |
Insufficient scRNA-seq data for expression of DTL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 90% | 598.46 | 1627 / 1809 | 95% | 25.37 | 450 / 472 |
lung | 90% | 190.02 | 520 / 578 | 91% | 17.12 | 1047 / 1155 |
breast | 67% | 64.78 | 309 / 459 | 95% | 23.99 | 1062 / 1118 |
intestine | 62% | 157.22 | 598 / 966 | 95% | 16.28 | 499 / 527 |
stomach | 54% | 82.70 | 193 / 359 | 95% | 17.26 | 273 / 286 |
esophagus | 48% | 170.51 | 699 / 1445 | 99% | 25.32 | 182 / 183 |
bladder | 48% | 47.81 | 10 / 21 | 91% | 14.94 | 458 / 504 |
uterus | 32% | 29.82 | 55 / 170 | 97% | 31.03 | 447 / 459 |
ovary | 30% | 33.41 | 54 / 180 | 91% | 11.08 | 393 / 430 |
thymus | 83% | 96.06 | 543 / 653 | 35% | 4.62 | 211 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.66 | 29 / 29 |
spleen | 100% | 484.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.88 | 1 / 1 |
liver | 30% | 51.52 | 67 / 226 | 57% | 7.14 | 232 / 406 |
pancreas | 17% | 11.97 | 55 / 328 | 68% | 5.79 | 121 / 178 |
adrenal gland | 48% | 47.54 | 125 / 258 | 28% | 3.00 | 65 / 230 |
adipose | 68% | 66.74 | 824 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 68% | 1136.33 | 628 / 929 | 0% | 0 | 0 / 0 |
prostate | 56% | 46.64 | 138 / 245 | 9% | 0.80 | 45 / 502 |
kidney | 29% | 40.52 | 26 / 89 | 34% | 2.67 | 303 / 901 |
brain | 5% | 3.17 | 128 / 2642 | 51% | 7.20 | 357 / 705 |
blood vessel | 29% | 22.05 | 384 / 1335 | 0% | 0 | 0 / 0 |
heart | 17% | 15.07 | 146 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 16% | 0.86 | 13 / 80 |
muscle | 6% | 3.21 | 46 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0009411 | Biological process | response to UV |
GO_0006260 | Biological process | DNA replication |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0019985 | Biological process | translesion synthesis |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0048511 | Biological process | rhythmic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005730 | Cellular component | nucleolus |
GO_0031464 | Cellular component | Cul4A-RING E3 ubiquitin ligase complex |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0031465 | Cellular component | Cul4B-RING E3 ubiquitin ligase complex |
GO_0005694 | Cellular component | chromosome |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DTL |
Protein name | Denticleless protein homolog (DDB1- and CUL4-associated factor 2) (Lethal(2) denticleless protein homolog) (Retinoic acid-regulated nuclear matrix-associated protein) Denticleless E3 ubiquitin protein ligase homolog |
Synonyms | L2DTL RAMP DCAF2 CDW1 CDT2 |
Description | FUNCTION: Substrate-specific adapter of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex required for cell cycle control, DNA damage response and translesion DNA synthesis. The DCX(DTL) complex, also named CRL4(CDT2) complex, mediates the polyubiquitination and subsequent degradation of CDT1, CDKN1A/p21(CIP1), FBH1, KMT5A and SDE2 . CDT1 degradation in response to DNA damage is necessary to ensure proper cell cycle regulation of DNA replication . CDKN1A/p21(CIP1) degradation during S phase or following UV irradiation is essential to control replication licensing . KMT5A degradation is also important for a proper regulation of mechanisms such as TGF-beta signaling, cell cycle progression, DNA repair and cell migration . Most substrates require their interaction with PCNA for their polyubiquitination: substrates interact with PCNA via their PIP-box, and those containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to their degradation. In undamaged proliferating cells, the DCX(DTL) complex also promotes the 'Lys-164' monoubiquitination of PCNA, thereby being involved in PCNA-dependent translesion DNA synthesis . The DDB1-CUL4A-DTL E3 ligase complex regulates the circadian clock function by mediating the ubiquitination and degradation of CRY1 . . |
Accessions | ENST00000542077.5 ENST00000366991.5 [Q9NZJ0-1] F5GZ90 Q9NZJ0 |